Similarly, in the retrospective analyses of the CRYSTAL and FIRE-3 29, AIO KRK-0104 trial 31, and CALGB/SWOG 80405 trial 28 higher OS and PFS were found among patients with LCC treated with anti-EGFR agents. Here, EGFR is linked to leukoencephalopathy with calcifications and cysts.